Research multi-target-multi-drug approaches need to be accelerated in the view of designing efficient therapeutic strategies against diseases bearing alterations in multiple cellular targets. Expression of untargeted protein leading desired or undesired off-target effects is one of the major concerns in performing multi-target-multi-drug approaches. In this study, we investigated the possibility of off-target effects of 4-phenylbutyrate and Iressa (Gefitinib) on the expression of vascular endothelial growth factor (VEGF) and histone deacetylase (HDAC), respectively. Treatment with 10 μM Iressa at the time of co-transfection or 48h after co-transfection of RFP-HDAC/YFP-VEGF plasmids in HEK 293 cells resulted in off-target effects on HDAC protein. These interesting results indicate possible applications of Iressa in the treatment of disease (e.g., Mantle cell lymphoma; MCL) wherein both the HDAC and VEGF protein needs be inhibited. 4-Phenylbutyrate (2.0 mM) did not show any off-target effects on VEGF protein. The developed techniques based on live/single cellular cotransfection imaging can be employed as a higher accuracy multi-target-multi-drug analysis tool at single cellular level to select better drug combinations.
한국생물공학회 [The Korean Society for Biotechnology and Bioengineering]
설립연도
1984
분야
공학>생물공학
소개
이 법인은 생물 공학의 발전과 보급에 이바지하고, 회원 상호 간의 연구 협력과 친목을 도모함을 목적으로 한다
1. 생물공학 분야의 발전을 위한 연구 협력
2. 생물공학의 실용화를 촉진시키기 위한 산학 협동
3. 학술연구 발표회, 강연회, 연수회 등 학술활동의 개최
4. 국,영문 학술지,소식지,학술회의 Proceedings 및 학술도서의 발간
5. 생물공학 발전을 위한 정책 건의
6. 기타 국제 교류 등 본 학회의 목적 달성을 위한 제반 활동